I

Intersect Ent Inc
F:7IN

Watchlist Manager
Intersect Ent Inc
F:7IN
Watchlist
Price: 27 EUR
Market Cap: 913m EUR

Net Margin
Intersect Ent Inc

-161.9%
Current
-74%
Average
1.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-161.9%
=
Net Income
-168.4m
/
Revenue
104m

Net Margin Across Competitors

No Stocks Found

Intersect Ent Inc
Glance View

Market Cap
912.9m EUR
Industry
Health Care

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company is headquartered in Menlo Park, California and currently employs 433 full-time employees. The company went IPO on 2014-07-24. The firm's steroid-releasing products are designed to provide mechanical spacing and deliver targeted therapy (mometasone furoate) to the site of disease. These products include its PROPEL family of products (PROPEL, PROPEL Mini and PROPEL Contour) and the SINUVA (mometasone furoate) Sinus Implant. The PROPEL family of products are used in adult patients to reduce inflammation and maintain patency following sinus surgery, primarily in hospitals and ambulatory surgery centers (ASC), with increasing applications in the physician office setting of care in conjunction with balloon dilation and following post-surgical debridement. SINUVA is a physician administered drug, designed to be used in the physician office setting of care to treat adult patients who have had ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company also offers ENT products, such as VenSure and CUBE.

7IN Intrinsic Value
Not Available
I
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-161.9%
=
Net Income
-168.4m
/
Revenue
104m
What is the Net Margin of Intersect Ent Inc?

Based on Intersect Ent Inc's most recent financial statements, the company has Net Margin of -161.9%.

Back to Top